- Home
- TS vs BNTX Comparison
TS vs BNTX Comparison
Compare TS & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TS | BNTX |
|---|---|---|
| Founded | 2001 | 2008 |
| Country | Luxembourg | Germany |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.3B | 24.7B |
| IPO Year | 2002 | 2019 |
Fundamental Metrics
Financial Performance| Metric | TS | BNTX |
|---|---|---|
| Price | $55.53 | $98.65 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 13 |
| Target Price | $58.80 | ★ $133.46 |
| AVG Volume (30 Days) | ★ 1.0M | 908.5K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.80% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1.53 | N/A |
| Revenue Next Year | $3.59 | $3.37 |
| P/E Ratio | $12.59 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $33.71 | $79.81 |
| 52 Week High | $64.60 | $124.00 |
Technical Indicators
Market Signals| Indicator | TS | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 48.93 | 48.97 |
| Support Level | $54.39 | $98.80 |
| Resistance Level | $58.72 | $112.78 |
| Average True Range (ATR) | 1.13 | 2.76 |
| MACD | -0.11 | -0.24 |
| Stochastic Oscillator | 29.14 | 45.61 |
Price Performance
Historical ComparisonAbout TS Tenaris S.A.
Tenaris SA is engaged in the manufacture and supply of steel pipe products and related services for the energy industry and other industrial applications. The company has one reportable segment, Tubes, which includes the production and sale of steel tubular products such as OCTG, line pipe, and mechanical and structural tubes, mainly for the oil and gas industry. It operates an integrated network of manufacturing, research, and service facilities across the Americas, Europe, the Middle East, Asia, and Africa.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.